Chatterjee, M <br/><br/>
Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancer.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  07 2016 
 - 1291-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdw174  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>B7-H1 Antigen--genetics<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Disease-Free Survival<br/>Dose-Response Relationship, Drug<br/>Drug-Related Side Effects and Adverse Reactions--pathology<br/>ErbB Receptors--genetics<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Prognosis<br/>Treatment Outcome